Clinical Trial Update: Safety and Efficacy Evaluation of an Extensively Hydrolyzed Formula in Infants With Cow's Milk Protein Allergy (CMPA) [NA]

View source ↗

Summary

This clinical trial update describes safety and efficacy evaluation of an extensively hydrolyzed formula in infants with cow's milk protein allergy. The study s…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Cow Milk Protein Allergy

Drugs mentioned

• Extensively Hydrolyzed Formula for CMPA

Snippet

Sponsor: Heilongjiang Feihe Dairy Co. Ltd. | Conditions: Cow's Milk Protein Allergy (CMPA) | NA | Status: NOT_YET_RECRUITING